Skip to main content
ArticleOPEN ACCESS

Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple–negative breast cancer

Chinese Journal of Cancer
DOI: 10.1186/s40880-017-0204-9
6Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Wang, D., Du, R., & Liu, S. (2017). Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple–negative breast cancer. Chinese Journal of Cancer. BioMed Central Ltd. https://doi.org/10.1186/s40880-017-0204-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free